|
Volumn 102, Issue 2, 1997, Pages 222-
|
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus- infected patients
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOPURINOL;
ANTIMONY DERIVATIVE;
COTRIMOXAZOLE;
METRONIDAZOLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG POTENTIATION;
HODGKIN DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
PRIORITY JOURNAL;
PROPHYLAXIS;
RELAPSE;
VISCERAL LEISHMANIASIS;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIPROTOZOAL AGENTS;
HUMANS;
LEISHMANIASIS, VISCERAL;
METRONIDAZOLE;
|
EID: 0030936375
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(96)00299-9 Document Type: Letter |
Times cited : (3)
|
References (5)
|